BACKGROUND: Exercise training improves exercise capacity (peakVO2), which is closely related to long-term survival in cardiac patients. However, it remains unclear which type and intensity of exercise is most effective for improving exercise tolerance and body weight. Individual studies suggest that aerobic interval training (AIT) might increase peakVO2 more in this population. OBJECTIVE: We conducted a meta-analysis to summarize the effects of AIT compared with moderate continuous training (MCT) on peakVO2, submaximal exercise capacity, and body weight in patients with coronary artery disease (CAD) with preserved and/or reduced left ventricular ejection fraction (LVEF). DATA SOURCES AND STUDY SELECTION: A systematic search was conducted and we included randomized trials comparing AIT and MCT in CAD patients lasting at least 4 weeks, reporting peakVO2 results, and published in a peer-reviewed journal up to May 2013. The primary outcome measure was peakVO2. Secondary outcomes were submaximal exercise capacity parameters and body weight. SYNTHESIS METHODS: Random- and fixed-effects models were used and data were reported as weighted means and 95% confidence intervals (CIs). RESULTS: Nine study groups were included, involving 206 patients (100 AIT, 106 MCT). Overall, AIT resulted in a significantly larger increase in peakVO2 [+1.60 mL/kg/min (95% CI 0.18-3.02; p = 0.03)] compared with MCT. MCT seemed to be more effective in reducing body weight (-0.78 kg; 95% CI -0.01 to 1.58; p = 0.05). LIMITATIONS: The small number of studies might have affected the power to reach significance for the secondary outcomes. CONCLUSION: In CAD patients with preserved and/or reduced LVEF, AIT is superior to MCT for improving peakVO2, while MCT seems to be more effective in reducing body weight. However, large, well-designed, randomized controlled trials are warranted to confirm these findings.
BACKGROUND: Exercise training improves exercise capacity (peakVO2), which is closely related to long-term survival in cardiac patients. However, it remains unclear which type and intensity of exercise is most effective for improving exercise tolerance and body weight. Individual studies suggest that aerobic interval training (AIT) might increase peakVO2 more in this population. OBJECTIVE: We conducted a meta-analysis to summarize the effects of AIT compared with moderate continuous training (MCT) on peakVO2, submaximal exercise capacity, and body weight in patients with coronary artery disease (CAD) with preserved and/or reduced left ventricular ejection fraction (LVEF). DATA SOURCES AND STUDY SELECTION: A systematic search was conducted and we included randomized trials comparing AIT and MCT in CAD patients lasting at least 4 weeks, reporting peakVO2 results, and published in a peer-reviewed journal up to May 2013. The primary outcome measure was peakVO2. Secondary outcomes were submaximal exercise capacity parameters and body weight. SYNTHESIS METHODS: Random- and fixed-effects models were used and data were reported as weighted means and 95% confidence intervals (CIs). RESULTS: Nine study groups were included, involving 206 patients (100 AIT, 106 MCT). Overall, AIT resulted in a significantly larger increase in peakVO2 [+1.60 mL/kg/min (95% CI 0.18-3.02; p = 0.03)] compared with MCT. MCT seemed to be more effective in reducing body weight (-0.78 kg; 95% CI -0.01 to 1.58; p = 0.05). LIMITATIONS: The small number of studies might have affected the power to reach significance for the secondary outcomes. CONCLUSION: In CAD patients with preserved and/or reduced LVEF, AIT is superior to MCT for improving peakVO2, while MCT seems to be more effective in reducing body weight. However, large, well-designed, randomized controlled trials are warranted to confirm these findings.
Authors: G F Fletcher; G J Balady; E A Amsterdam; B Chaitman; R Eckel; J Fleg; V F Froelicher; A S Leon; I L Piña; R Rodney; D A Simons-Morton; M A Williams; T Bazzarre Journal: Circulation Date: 2001-10-02 Impact factor: 29.690
Authors: Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers Journal: Eur Heart J Date: 2012-09-05 Impact factor: 29.983
Authors: Steven J Keteyian; Clinton A Brawner; Patrick D Savage; Jonathan K Ehrman; John Schairer; George Divine; Heather Aldred; Kristin Ophaug; Philip A Ades Journal: Am Heart J Date: 2008-05-22 Impact factor: 4.749
Authors: Filippo Maria Sarullo; Giovanni Fazio; Ignazio Brusca; Sergio Fasullo; Salvatore Paterna; Pamela Licata; Giuseppina Novo; Salvatore Novo; Pietro Di Pasquale Journal: Open Cardiovasc Med J Date: 2010-05-26
Authors: Dae Yun Seo; Hyo-Bum Kwak; Amy Hyein Kim; Se Hwan Park; Jun Won Heo; Hyoung Kyu Kim; Jeong Rim Ko; Sam Jun Lee; Hyun Seok Bang; Jun Woo Sim; Min Kim; Jin Han Journal: Pflugers Arch Date: 2019-04-23 Impact factor: 3.657
Authors: Prisca Eser; Lukas D Trachsel; Thimo Marcin; David Herzig; Irina Freiburghaus; Stefano De Marchi; Andreas J Zimmermann; Jean-Paul Schmid; Matthias Wilhelm Journal: Front Cardiovasc Med Date: 2022-06-17
Authors: D M L Prado; E A Rocco; A G Silva; D F Rocco; M T Pacheco; P F Silva; V Furlan Journal: Braz J Med Biol Res Date: 2016-02-05 Impact factor: 2.590